FDA, pharmaceutical industry reach agreement on user-fee plan for generics

Download PDF Copy

Jan 19 2012

The Washington Post: FDA And Drug Industry Agree On User-Fee Proposal For Generics
The Food and Drug Administration would collect hundreds of millions of dollars in new fees from pharmaceutical companies to help speed up the review of generic drugs, under an agreement with the industry released by the agency on Friday (Perrone, 1/17).

This article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Business / Finance | Pharmaceutical News

Tags: Drugs, Food, Health Care, Pharmaceuticals, Research

Comments (0)

Download PDF Copy

Suggested Reading

Breakthrough pig kidney transplant ends dialysis for Alabama woman

Breakthrough pig kidney transplant ends dialysis for Alabama woman

Non-toxic bacterial therapy shows promise for targeting tumors

Non-toxic bacterial therapy shows promise for targeting tumors

Study reveals how fatty liver disease leads to liver cancer

Study reveals how fatty liver disease leads to liver cancer

New modular strategy reduces piperidine synthesis steps for pharmaceuticals

New modular strategy reduces piperidine synthesis steps for pharmaceuticals

U.S. wastewater treatment fails to address rising organofluorine contamination

U.S. wastewater treatment fails to address rising organofluorine contamination

A new strategy for enhancing the production of protein-based drugs

A new strategy for enhancing the production of protein-based drugs

Annona squamosa extracts show promise in treating pain and arthritis

Annona squamosa extracts show promise in treating pain and arthritis

Imlunestrant offers new hope for ER-positive HER2-negative breast cancer

Imlunestrant offers new hope for ER-positive HER2-negative breast cancer

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

Post

Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net.

To start a conversation, please log into your AZoProfile account first, or create a new account.

Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content.

A few things you need to know before we start. Please read and accept to continue.

Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI.
Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy.
Large Language Models can make mistakes. Consider checking important information.

I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements.

Please check the box above to proceed.

Great. Ask your question.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...

Carrots may offer natural support for people with type 2 diabetes